Novo Nordisk Expands GLP-1 Reach With Oral Ozempic And Pediatric Push
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
Canada approves second generic version of Ozempic
OTTAWA, May 1 (Reuters) – The Canadian health regulator said on Friday that it had approved Canada-based Apotex’s…
Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM USA – English USA – English
Published pivotal FRONTIER2 study showed investigational denecimig significantly reduced annualized bleeding rate compared to prior clotting factor prophylaxis…
Can Oral Ozempic and Label Expansions Revive NVO’s Near-Term Growth?
Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…
Which Healthcare Giant Is the Better Bet?
Novo Nordisk NVO and Pfizer PFE are both pharmaceutical giants based in Denmark and the United States, respectively, with…
Lilly’s Foundayo hits 1,390 prescriptions in debut week
April 17 (Reuters) – Eli Lilly’s newly launched obesity pill was prescribed 1,390 times in the U.S. as…
Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?
Picking winning stocks could lead your portfolio into millionaire territory over time — so it’s important to choose…
Weight-Loss Injections Become Part of Pre-Wedding Preparation
HYDERABAD: Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest…
Generic versions of weight-loss drugs should arrive on Canadian pharmacy shelves this summer
With the expiration of the Canadian patents for weight-loss drugs Ozempic and Wegovy in January, experts are looking…
As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices | Industry News
Amid competition from cheaper generics, Danish drugmaker Novo Nordisk on Monday announced price cuts of up to…
Dr. Reddy’s can supply leftover Olymviq stock to government hospitals after 30-day window
The Delhi High Court has allowed Dr. Reddy’s Laboratories to supply any remaining stock of its semaglutide drug…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…